Educating Physicians on the Benefits of Blood Pressure Management as a Potential Mechanism to Reduce the Risk of Cognitive Decline and Dementia
Year: 2018
Type: conference-abstract
Abstract: Cognitive impairment, including clinical Alzheimer’s-type dementia (CATD), mild cognitive impairment (MCI), or age-related cognitive decline (ARCD), affects a growing number of older adults. Given the impact of cognitive impairment on society, there is increasing interest on evidence-informed risk reduction of cognitive impairment. In 2015, the National Institute on Aging (NIA) asked the National Academies of Sciences, Engineering, and Medicine (NASEM) to examine the evidence of interventions for preventing, slowing, or delaying the onset of MCI and CATD, and delaying or slowing ARCD. The 2017 NASEM report indicated that blood pressure management for people with hypertension can prevent, delay, or slow cognitive impairment, including ARCD, MCI, or CATD. To respond to the recent evidence on risk reduction of cognitive decline, CDC and ACPM developed a continuing education module to improve healthcare providers’ ability to utilize blood pressure control in middle-aged adults to reduce risk of cognitive impairment in later life.
Source: Innovation in Aging
Author: M Hudson
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,977
OpenAlex ID: W2899525860